Search
L-tartaric acid
go.drugbank.com/drugs/DB09459Approved, and is a dihydroxyl derivative of succinic acid. … Tartaric acid is a white crystalline organic acid that occurs naturally in many plants, most notably in grapes.Tartaric is an alpha-hydroxy-carboxylic acid, is diprotic and aldaric in acid characteristics
Mixtures: U-Lite Effervescent GranulesHEPES
go.drugbank.com/drugs/DB16872InvestigationalCategories: Compounds used in a research, industrial, or household settingp-Coumaric acid
go.drugbank.com/drugs/DB04066ExperimentalCategories: Compounds used in a research, industrial, or household settingHematin
go.drugbank.com/drugs/DB13387InvestigationalCategories: Heterocyclic Compounds with 4 or More RingsIsoxsuprine
go.drugbank.com/drugs/DB08941ApprovedWithdrawnA beta-adrenergic agonist that causes direct relaxation of uterine and vascular smooth muscle. … Its vasodilating actions are greater on the arteries supplying skeletal muscle than on those supplying skin. It is used in the treatment of peripheral vascular disease and in premature labor.
GPI-0100
go.drugbank.com/drugs/DB05929InvestigationalGPI-0100 is Avantogen’s lead adjuvanat-immunopotentiator, a key component of vaccines for boosting the immune response. … The GPI-0100 adjuvant, which has been shown to significantly enhance the immune response with a variety of vaccines, has been shown to have good overall performance characteristics on safety and efficacy
Fenspiride
go.drugbank.com/drugs/DB08979Investigational), as well as for maintenance treatment of asthma. … Fenspiride is an oxazolidinone spiro compound used as a drug in the treatment of certain respiratory diseases.
SR-123781A
go.drugbank.com/drugs/DB05361InvestigationalSR-123781A is a synthetic hexadecasaccharide Factor IIa and Xa antagonist. It is under investigation by Sanofi-Aventis and Organon for the treatment of thrombosis and acute coronary syndromes (ACS).
Pilaralisib
go.drugbank.com/drugs/DB11772InvestigationalPilaralisib is an orally available small molecule that selectively inhibits the activity of phosphoinositide-3 kinase (PI3K). … Pilaralisib has been used in trials studying the treatment of Cancer, Lymphoma, Solid Tumors, Glioblastoma, and Breast Cancer, among others.
XmAb 2513
go.drugbank.com/drugs/DB06324InvestigationalXmAb 2513 is a humanized monoclonal antibody that targets the antigen CD30, a molecule expressed on the surface of a number of tumor cell types. … It has been investigated for the treatment of hodgkin’s lymphoma.